RE:Breast cancer treatment: perspectives on the oncolytic virus
The advent of precision medicine calls for advancements in identifying predictive biomarkers for treatment response remain also urgent. Identifying biomarkers associated with the efficacy of OVs can aid in patient stratification, ensuring targeted therapies for individuals most likely to benefit.
https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36118147